More on XNCR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.95 |
|
|||
| Open | $14.68 | ||||
| 52 Wk High | $26.50 | ||||
| 52 Wk Low | $9.89 | ||||
| Day High | $17.68 | ||||
| Day Low | $14.60 | ||||
| P/E | N/A | ||||
| EPS | $-0.51 | ||||
| Volume | 1,683,095 | ||||
- Xencor to present XmAb819 renal cancer data at ESMO 2026
- Xencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
- Form 4 Xencor Inc For: Jun 16 Filed by: Feigal Ellen
- Form 4 Xencor Inc For: Jun 16 Filed by: GORMAN KEVIN CHARLES
- Form 4 Xencor Inc For: Jun 16 Filed by: GUSTAFSON KURT A
- Form 4 Xencor Inc For: Jun 16 Filed by: Klencke Barbara
- Form 4 Xencor Inc For: Jun 16 Filed by: Montgomery Alan Bruce
- Form 4 Xencor Inc For: Jun 16 Filed by: RANIERI RICHARD J
- Form 4 Xencor Inc For: Jun 16 Filed by: SIMPSON TODD E
- Form 4 Xencor Inc For: Jun 16 Filed by: Deshaies Raymond Joseph
Entities mentioned with XNCR
- Earnings | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- RBC Capital | View Related Stories »
- Show More...
